Suven Life Sciences Limited has informed the Exchange regarding a press release dated Jun 12, 2026, titled "Suven Life Sciences announces three poster presentations on Samelisant (SUVN-G3031), including global Phase-3, AWAKE Narcolepsy Study at the SLEEP-2026 Annual Meeting being held at Baltimore, USA".